|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
|
US4501728A
(en)
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
|
US5019369A
(en)
|
1984-10-22 |
1991-05-28 |
Vestar, Inc. |
Method of targeting tumors in humans
|
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US4920016A
(en)
|
1986-12-24 |
1990-04-24 |
Linear Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5539082A
(en)
|
1993-04-26 |
1996-07-23 |
Nielsen; Peter E. |
Peptide nucleic acids
|
|
US5719262A
(en)
|
1993-11-22 |
1998-02-17 |
Buchardt, Deceased; Ole |
Peptide nucleic acids having amino acid side chains
|
|
US5714331A
(en)
|
1991-05-24 |
1998-02-03 |
Buchardt, Deceased; Ole |
Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility
|
|
US5837258A
(en)
|
1991-08-30 |
1998-11-17 |
University Of South Florida |
Induction of tissue, bone or cartilage formation using connective tissue growth factor
|
|
US6794499B2
(en)
|
1997-09-12 |
2004-09-21 |
Exiqon A/S |
Oligonucleotide analogues
|
|
US7572582B2
(en)
|
1997-09-12 |
2009-08-11 |
Exiqon A/S |
Oligonucleotide analogues
|
|
US7084125B2
(en)
|
1999-03-18 |
2006-08-01 |
Exiqon A/S |
Xylo-LNA analogues
|
|
JP2002543214A
(ja)
|
1999-05-04 |
2002-12-17 |
エクシコン エ／エス |
Ｌ−リボ−ｌｎａ類縁体
|
|
DE10160151A1
(de)
|
2001-01-09 |
2003-06-26 |
Ribopharma Ag |
Verfahren zur Hemmung der Expression eines vorgegebenen Zielgens
|
|
US20040259247A1
(en)
|
2000-12-01 |
2004-12-23 |
Thomas Tuschl |
Rna interference mediating small rna molecules
|
|
US20080188430A1
(en)
|
2001-05-18 |
2008-08-07 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)
|
|
US20050282188A1
(en)
|
2001-05-18 |
2005-12-22 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)
|
|
AU2002334307A1
(en)
|
2001-09-04 |
2003-03-18 |
Exiqon A/S |
Novel lna compositions and uses thereof
|
|
JP2005506087A
(ja)
|
2001-10-26 |
2005-03-03 |
リボファーマ アーゲー |
プラス鎖ｒｎａウイルスによる感染症を処置するための２本鎖リボ核酸の使用
|
|
US20040138163A1
(en)
|
2002-05-29 |
2004-07-15 |
Mcswiggen James |
RNA interference mediated inhibition of vascular edothelial growth factor and vascular edothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
|
KR100464261B1
(ko)
|
2002-01-24 |
2005-01-03 |
주식회사 파나진 |
Ｐｎａ 올리고머를 합성하기 위한 신규한 단량체 및 그의제조방법
|
|
KR20030084444A
(ko)
|
2002-04-26 |
2003-11-01 |
주식회사 파나진 |
Ｐｎａ 올리고머를 합성하기 위한 신규한 단량체 및 그의제조방법
|
|
US7569575B2
(en)
|
2002-05-08 |
2009-08-04 |
Santaris Pharma A/S |
Synthesis of locked nucleic acid derivatives
|
|
PT1527176E
(pt)
|
2002-08-05 |
2007-04-30 |
Atugen Ag |
Novas formas de muléculas de arn de interferência
|
|
DK2284266T3
(da)
|
2002-11-14 |
2014-01-13 |
Thermo Fisher Scient Biosciences Inc |
sIRNA-MOLEKYLE MOD TP53
|
|
WO2006006948A2
(en)
|
2002-11-14 |
2006-01-19 |
Dharmacon, Inc. |
METHODS AND COMPOSITIONS FOR SELECTING siRNA OF IMPROVED FUNCTIONALITY
|
|
EP2216407B1
(en)
|
2003-03-07 |
2016-01-13 |
Alnylam Pharmaceuticals, Inc. |
Therapeutic compositions
|
|
US20040198640A1
(en)
|
2003-04-02 |
2004-10-07 |
Dharmacon, Inc. |
Stabilized polynucleotides for use in RNA interference
|
|
US7211668B2
(en)
|
2003-07-28 |
2007-05-01 |
Panagene, Inc. |
PNA monomer and precursor
|
|
US20050136437A1
(en)
|
2003-08-25 |
2005-06-23 |
Nastech Pharmaceutical Company Inc. |
Nanoparticles for delivery of nucleic acids and stable double-stranded RNA
|
|
EA009670B1
(ru)
*
|
2003-09-18 |
2008-02-28 |
Ай Эс Ай Эс ФАРМАСЬЮТИКАЛЗ, ИНК. |
МОДУЛИРОВАНИЕ ЭКСПРЕССИИ eIF4E
|
|
US20060134787A1
(en)
|
2004-12-22 |
2006-06-22 |
University Of Massachusetts |
Methods and compositions for enhancing the efficacy and specificity of single and double blunt-ended siRNA
|
|
WO2005062937A2
(en)
|
2003-12-22 |
2005-07-14 |
University Of Massachusetts |
Methods and compositions for enhancing the efficacy and specificity of single and double blunt-ended sirna
|
|
WO2005079533A2
(en)
|
2004-02-17 |
2005-09-01 |
University Of Massachusetts |
Methods and compositions for mediating gene silencing
|
|
CA2558771C
(en)
|
2004-03-05 |
2013-01-08 |
Benitec, Inc. |
Multiple promoter expression cassettes for simultaneous delivery of rnai agents
|
|
EP2365077B1
(en)
|
2004-03-12 |
2013-05-08 |
Alnylam Pharmaceuticals, Inc. |
iRNA agents targeting VEGF
|
|
KR101147147B1
(ko)
|
2004-04-01 |
2012-05-25 |
머크 샤프 앤드 돔 코포레이션 |
Ｒｎａ 간섭의 오프 타겟 효과 감소를 위한 변형된폴리뉴클레오타이드
|
|
JP2008512500A
(ja)
|
2004-09-10 |
2008-04-24 |
ソマジェニックス インコーポレーティッド |
ウィルス遺伝子発現を効率的に阻害する低分子干渉ｒｎａおよびその使用方法
|
|
NZ586217A
(en)
|
2004-09-24 |
2011-12-22 |
Alnylam Pharmaceuticals Inc |
RNAI modulation of APOB and uses thereof
|
|
US20060142228A1
(en)
|
2004-12-23 |
2006-06-29 |
Ambion, Inc. |
Methods and compositions concerning siRNA's as mediators of RNA interference
|
|
TWI386225B
(zh)
|
2004-12-23 |
2013-02-21 |
Alcon Inc |
用於治療眼睛病症的結締組織生長因子（ＣＴＧＦ）ＲＮＡ干擾（ＲＮＡｉ）抑制技術
|
|
WO2006110688A2
(en)
|
2005-04-08 |
2006-10-19 |
Nastech Pharmaceutical Company Inc. |
Rnai therapeutic for respiratory virus infection
|
|
WO2006125977A2
(en)
|
2005-05-25 |
2006-11-30 |
The University Of York |
Hybrid interfering rna
|
|
NZ564375A
(en)
|
2005-06-24 |
2010-02-26 |
Intervet Int Bv |
Inactivated chimeric flavivirus vaccines and related methods of use
|
|
FR2890859B1
(fr)
|
2005-09-21 |
2012-12-21 |
Oreal |
Oligonucleotide d'arn double brin inhibant l'expression de la tyrosinase
|
|
US7825099B2
(en)
*
|
2006-01-20 |
2010-11-02 |
Quark Pharmaceuticals, Inc. |
Treatment or prevention of oto-pathologies by inhibition of pro-apoptotic genes
|
|
WO2007092182A2
(en)
|
2006-01-26 |
2007-08-16 |
University Of Massachusetts |
Rna interference agents for therapeutic use
|
|
CN103215293B
(zh)
|
2006-01-27 |
2015-10-28 |
比奥根Ma公司 |
Nogo受体拮抗剂
|
|
US20070218495A1
(en)
|
2006-03-16 |
2007-09-20 |
Dharmacon, Inc. |
Methods, libraries and computer program products for gene silencing with reduced off-target effects
|
|
US7700541B2
(en)
|
2006-04-06 |
2010-04-20 |
Nitto Denko Corporation |
Biodegradable cationic polymers
|
|
GB0608838D0
(en)
|
2006-05-04 |
2006-06-14 |
Novartis Ag |
Organic compounds
|
|
WO2008109377A1
(en)
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting vegf family gene expression and uses thereof
|
|
US20100105134A1
(en)
|
2007-03-02 |
2010-04-29 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting gene expression and uses thereof
|
|
CA2691617C
(en)
|
2007-05-31 |
2020-07-21 |
University Of Iowa Research Foundation |
Reduction of off-target rna interference toxicity
|
|
US20090004668A1
(en)
|
2007-06-22 |
2009-01-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Pre-miRNA loop-modulated target regulation
|
|
AU2008270209B2
(en)
*
|
2007-07-05 |
2012-05-17 |
Arrowhead Pharmaceuticals, Inc. |
dsRNA for treating viral infection
|
|
WO2009008725A2
(en)
|
2007-07-12 |
2009-01-15 |
Prosensa Technologies B.V. |
Molecules for targeting compounds to various selected organs, tissues or tumor cells
|
|
WO2009020344A2
(en)
|
2007-08-06 |
2009-02-12 |
Postech Acad Ind Found |
Small interfering rnas (sirnas) controlling multiple target genes and method for preparing the same
|
|
WO2009029688A2
(en)
|
2007-08-27 |
2009-03-05 |
Boston Biomedical, Inc. |
Compositions of asymmetric interfering rna and uses thereof
|
|
DK2195428T3
(en)
|
2007-09-19 |
2014-03-03 |
Applied Biosystems Llc |
SIRNA SEQUENCE-INDEPENDENT MODIFICATION FORMS TO REDUCE TARGET-FAILING PHENOTYPIC EFFECTS OF RNAI, AND STABILIZED FORMS THEREOF
|
|
US8614309B2
(en)
|
2007-10-03 |
2013-12-24 |
Quark Pharmaceuticals, Inc. |
Double-stranded RNA directed to CASP2 and methods of use thereof
|
|
WO2009065022A2
(en)
|
2007-11-15 |
2009-05-22 |
Alcon Research, Ltd. |
Low density lipoprotein receptor-mediated sirna delivery
|
|
US8614311B2
(en)
|
2007-12-12 |
2013-12-24 |
Quark Pharmaceuticals, Inc. |
RTP801L siRNA compounds and methods of use thereof
|
|
KR100949791B1
(ko)
|
2007-12-18 |
2010-03-30 |
이동기 |
오프-타겟 효과를 최소화하고 ＲＮＡｉ 기구를 포화시키지않는 신규한 ｓｉＲＮＡ 구조 및 그 용도
|
|
JP2011518116A
(ja)
|
2008-02-21 |
2011-06-23 |
ユニバーシティ オブ ケンタッキー リサーチ ファウンデーション |
トール様受容体３拮抗薬としての超小型ｒｎａ
|
|
US8324366B2
(en)
|
2008-04-29 |
2012-12-04 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for delivering RNAI using lipoproteins
|
|
CA2731779A1
(en)
|
2008-07-24 |
2010-01-28 |
Rxi Pharmaceuticals Corporation |
Rnai constructs and uses therof
|
|
AU2009279857A1
(en)
*
|
2008-08-04 |
2010-02-11 |
Idera Pharmaceuticals, Inc. |
Modulation of toll-like receptor 3 expression by antisense oligonucleotides
|
|
AU2009279524A1
(en)
*
|
2008-08-08 |
2010-02-11 |
Idera Pharmaceuticals, Inc. |
Modulation of myeloid differentiation primary response gene 88 (MYD88) expression by antisense oligonucleotides
|
|
JP5294344B2
(ja)
|
2008-09-08 |
2013-09-18 |
学校法人福岡大学 |
白血病治療用医薬組成物
|
|
CN102405286A
(zh)
|
2008-09-22 |
2012-04-04 |
阿克赛医药公司 |
减小大小的自递送RNAi化合物
|
|
US20100227920A1
(en)
|
2008-09-29 |
2010-09-09 |
The Regents Of The University Of California |
Aldehyde dehydrogenase inhibitors as novel depigmenting agents
|
|
WO2010090762A1
(en)
|
2009-02-04 |
2010-08-12 |
Rxi Pharmaceuticals Corporation |
Rna duplexes with single stranded phosphorothioate nucleotide regions for additional functionality
|
|
EP2398903A1
(en)
|
2009-02-18 |
2011-12-28 |
Silence Therapeutics Aktiengesellschaft |
Means for inhibiting the expression of ang2
|
|
WO2010107952A2
(en)
|
2009-03-19 |
2010-09-23 |
Merck Sharp & Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF CONNECTIVE TISSUE GROWTH FACTOR (CTGF) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
|
CN104651362A
(zh)
|
2009-04-03 |
2015-05-27 |
戴瑟纳制药公司 |
利用不对称双链rna特异性抑制kras的方法和组合物
|
|
US8472766B2
(en)
|
2009-08-14 |
2013-06-25 |
Massachusetts Institute Of Technology |
Waveguide coupler having continuous three-dimensional tapering
|
|
KR101207561B1
(ko)
|
2009-12-15 |
2012-12-04 |
주식회사 코리아나화장품 |
티로시나제의 발현을 저해하는 ｓｉＲＮＡ 올리고뉴클레오타이드 및 이를 함유하는 화장료 조성물
|
|
WO2011084193A1
(en)
|
2010-01-07 |
2011-07-14 |
Quark Pharmaceuticals, Inc. |
Oligonucleotide compounds comprising non-nucleotide overhangs
|
|
SG183374A1
(en)
|
2010-02-24 |
2012-09-27 |
Arrowhead Res Corp |
Compositions for targeted delivery of sirna
|
|
CN106074591B
(zh)
|
2010-03-24 |
2020-01-14 |
菲奥医药公司 |
眼部症候中的rna干扰
|
|
CA2834108A1
(en)
|
2010-05-12 |
2011-11-17 |
Val-Chum, Limited Partnership |
Screening assays based on mag and/or abhd6 for selecting insulin secretion promoting agents
|
|
WO2012037254A1
(en)
|
2010-09-15 |
2012-03-22 |
Alnylam Pharmaceuticals, Inc. |
MODIFIED iRNA AGENTS
|
|
EP3599280B1
(en)
|
2010-10-22 |
2022-11-02 |
OliX Pharmaceuticals, Inc. |
Nucleic acid molecules inducing rna interference, and uses thereof
|
|
EP2649181B1
(en)
*
|
2010-12-06 |
2016-04-27 |
Quark Pharmaceuticals, Inc. |
Double stranded oligonucleotide compounds comprising positional modifications
|
|
US8501930B2
(en)
|
2010-12-17 |
2013-08-06 |
Arrowhead Madison Inc. |
Peptide-based in vivo siRNA delivery system
|
|
BR122020024388B1
(pt)
|
2010-12-29 |
2021-09-21 |
F. Hoffmann-La Roche Ag |
Oligonucleotídeo e composição farmacêutica
|
|
EP2681315B1
(en)
|
2011-03-03 |
2017-05-03 |
Quark Pharmaceuticals, Inc. |
Oligonucleotide modulators of the toll-like receptor pathway
|
|
CN102719432B
(zh)
|
2011-03-29 |
2013-10-23 |
南京大学 |
特异性抑制肿瘤凋亡抑制基因Bcl2的双链不对称小核酸干扰分子asiRNA及其应用
|
|
KR101590586B1
(ko)
|
2011-05-30 |
2016-02-01 |
성균관대학교산학협력단 |
표적 유전자 발현 억제 및 면역 반응을 동시에 유발하는 이중가닥의 긴 간섭 ｒｎａ
|
|
CN103889461B
(zh)
*
|
2011-07-18 |
2016-11-09 |
肯塔基大学研究基金会 |
保护细胞免于alu-rna诱导的变性和用于保护细胞的抑制剂
|
|
US9707235B1
(en)
|
2012-01-13 |
2017-07-18 |
University Of Kentucky Research Foundation |
Protection of cells from degeneration and treatment of geographic atrophy
|
|
JP2015509922A
(ja)
|
2012-01-27 |
2015-04-02 |
プロセンサ テクノロジーズ ビー．ブイ．Ｐｒｏｓｅｎｓａ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｂ．Ｖ． |
デュシェンヌ型及びベッカー型筋ジストロフィーの治療のための改善された特徴を有するｒｎａ調節オリゴヌクレオチド
|
|
CN104755620B
(zh)
*
|
2012-05-22 |
2018-03-02 |
奥利克斯医药有限公司 |
具有细胞内穿透能力的诱导rna干扰的核酸分子及其用途
|
|
US9611473B2
(en)
*
|
2012-09-12 |
2017-04-04 |
Quark Pharmaceuticals, Inc. |
Double-stranded nucleic acid compounds
|
|
US20160122764A1
(en)
|
2013-07-05 |
2016-05-05 |
Bioneer Corporation |
Respiratory disease-related gene specific sirna, double-helical oligo rna structure containing sirna, compositon containing same for preventing or treating respiratory disease
|
|
EP3027223A1
(en)
*
|
2013-07-31 |
2016-06-08 |
QBI Enterprises Ltd. |
Methods of use of sphingolipid polyalkylamine oligonucleotide compounds
|
|
US9790506B2
(en)
|
2013-10-02 |
2017-10-17 |
The Regents Of The University Of California |
Diagnostic and screening methods for atopic dermatitis
|
|
US8980273B1
(en)
|
2014-07-15 |
2015-03-17 |
Kymab Limited |
Method of treating atopic dermatitis or asthma using antibody to IL4RA
|
|
US20170226507A1
(en)
|
2014-05-05 |
2017-08-10 |
The Brigham And Women's Hospital, Inc. |
Coordinate control of pathogenic signaling by the mir-130/301 family in pulmonary hypertension and fibroproliferative diseases
|
|
US9139648B1
(en)
|
2014-07-15 |
2015-09-22 |
Kymab Limited |
Precision medicine by targeting human NAV1.9 variants for treatment of pain
|
|
EP3277811B1
(en)
|
2015-04-03 |
2020-12-23 |
University of Massachusetts |
Fully stabilized asymmetric sirna
|
|
WO2017017523A1
(en)
|
2015-07-27 |
2017-02-02 |
Olix Pharmaceuticals, Inc. |
Rna complexes that inhibit melanin production
|
|
KR102727666B1
(ko)
|
2015-11-16 |
2024-11-08 |
올릭스 주식회사 |
MyD88 또는 TLR3을 타겟팅하는 RNA 복합체를 이용한 연령-관련 황반 변성의 치료
|
|
KR102825946B1
(ko)
|
2016-02-02 |
2025-06-27 |
올릭스 주식회사 |
IL4Rα, TRPA1, 또는 F2RL1을 표적화하는 RNA 복합체를 사용한 아토피 피부염 및 천식의 치료
|
|
US10519449B2
(en)
|
2016-02-02 |
2019-12-31 |
Olix Pharmaceuticals, Inc. |
Treatment of angiogenesis-associated diseases using RNA complexes that target ANGPT2 and PDGFB
|
|
CN105748782A
(zh)
*
|
2016-02-25 |
2016-07-13 |
太和县中医院 |
一种用于治疗颈椎病的中药口服液
|
|
KR102339886B1
(ko)
|
2016-04-11 |
2021-12-17 |
올릭스 주식회사 |
연결 조직 성장 인자를 표적화하는 rna 복합체를 사용한 특발성 폐 섬유증의 치료 방법
|
|
KR101916652B1
(ko)
|
2016-06-29 |
2018-11-08 |
올릭스 주식회사 |
작은 간섭 rna의 rna 간섭효과 증진용 화합물 및 이의 용도
|
|
EP3580339A4
(en)
|
2017-02-10 |
2020-12-23 |
Research & Business Foundation Sungkyunkwan University |
LONG DOUBLE STRAND RNA FOR RNA INTERFERENCE
|